Molecular Templates Announces Debt Payoff and Restructuring

Molecular Templates, a clinical-stage biopharmaceutical company focused on developing targeted biologic therapeutics for cancer, has announced a restructuring agreement with K2 HealthVentures to fully discharge and satisfy outstanding debt obligations. The agreement also includes the granting of contingent value rights and warrants. Molecular Templates will reduce its current workforce by approx..